Items in AFP with MESH term: Colorectal Neoplasms

Pages: Previous 1 2 3 Next

Flexible Sigmoidoscopy - Article


Medicare Expands Preventive Screening Benefits - Getting Paid


Screening for Colorectal Cancer: Recommendation and Rationale - U.S. Preventive Services Task Force


Postmenopausal Hormone Replacement Therapy for the Primary Prevention of Chronic Conditions - U.S. Preventive Services Task Force


ACS Releases Guidelines on Nutrition and Physical Activity During and After Cancer Treatment - Practice Guidelines


ACS Guidelines for Early Detection of Cancer - Practice Guidelines


Calcium and Prevention of Colorectal Cancer - Cochrane for Clinicians


Colorectal Cancer Screening: Don't Just Do It, Do It Right - Editorials


Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: Recommendation Statement - U.S. Preventive Services Task Force


Colonoscopy Surveillance After Polypectomy and Colorectal Cancer Resection - Article

ABSTRACT: This article describes a joint update of guidelines by the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer delineating evidence-based surveillance recommendations for patients after polypectomy and colorectal cancer resection. Although there are some qualifying conditions, the following general guidelines apply: after colonoscopic polypectomy, patients with hyperplastic polyps should be considered to have normal colonoscopies, and subsequent colonoscopy is recommended at 10 years. Patients with one or two small (less than 1 cm) tubular adenomas, including those with only low-grade dysplasia, should have their next colonoscopy in five to 10 years. Patients with three to 10 adenomas, any adenoma 1 cm or larger, or any adenoma with villous features or high-grade dysplasia should have their next colonoscopy in three years. Following curative resection of colorectal cancer, patients should undergo a colonoscopy at one year, with subsequent follow-up intervals determined by the results of this examination. Adoption of these guidelines will have a dramatic impact on the quality of care provided to patients after a colorectal cancer diagnosis, will assist in shifting available resources from intensive surveillance to screening, and will ultimately decrease suffering and death related to colorectal cancer.


Pages: Previous 1 2 3 Next


Information From Industry